added that Lemonaid now offers weight loss care, prescribing GLP-1
Thyroid tumor risk: Individuals with a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2) should avoid tirzepatide due to the risk of thyroid tumors
The incidence of malformations exceeded concurrent and historical controls at 0.01 mg/kg/day (kidneys, scapula), 0.01 mg/kg/day (eyes, forelimb), 0.025 mg/kg/day (brain, tail and sacral vertebrae, major blood vessels and heart, umbilicus), 0.025 mg/kg/day (sternum) and at 0.05 mg/kg/day (parietal bones, major blood vessels)
Therefore, this hormone could be a promising candidate for combination therapy with GLP-1 for better control of T2D
Lautenbach A, Kantowski T, Wagner J, et al
2024- - () CLA ( (), (), (FM), (BFP) (FFM))